Insider · CIK 0002015934
Gregory Louis Merril
Files at HLSQ (BiomX Inc.). First filing -, latest -.
Gregory Louis Merril files SEC Form 4 as director at HLSQ (BiomX Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregory Louis Merril has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - right to Buyderivative | +17,600 | $0.00 | $0 | 17,600 | Apr 21, 2025 |
| Apr 14, 2025 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - right to Buyderivative | -17,600 | $0.00 | $0 | 17,600 | Apr 18, 2025 |
Questions about Gregory Louis Merril
Answered from the filings on this page, as of the latest one.
Is Gregory Louis Merril buying or selling?
Gregory Louis Merril has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregory Louis Merril's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory Louis Merril has 0.
Where does Gregory Louis Merril file Form 4?
Gregory Louis Merril has filed Form 4 at HLSQ (BiomX Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.